|
|
|
Supply Chain Management in the Drug Industry: Delivering Patient Value for Pharmaceuticals and Biologics
|
(Buch) |
Dieser Artikel gilt, aufgrund seiner Grösse, beim Versand als 3 Artikel!
| Inhalt: |
| "...[This] interesting exploration of SCM issues includes business, control, regulatory and technical aspects. . . .a must-read for those entering into the SCM fields as well as all those who intersect with SCM."
--Bob Coleman, former FDA Investigator and current Senior Compliance Expert, IHL Consulting Group, Inc.
A timely guide for improving productivity, driving out cost, aising quality
In response to the global pressure to contain healthcare budgets while improving compliance, the pharmaceutical industry is moving supply chain center stage, in an attempt to build supply chains comparable with the aerospace, semi-conductor, electronics, and automotive industries. This book bridges the gap between practitioners of supply chain management and pharmaceutical industry experts. It shows them how to jointly contribute to meaningful improvements in supply chains within the pharmaceutical sector.
Supply Chain Management in the Drug Industry suggests that CMC (chemistry, manufacturing, and controls) drug development must reset the line of sight--from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. In addition, the book:
* Provides a practical guide to the application of supply chain management (SCM) processes and practices in the pharmaceutical setting
* Stresses the importance of integrated SCM throughout a pharmaceutical organization
* Encourages the critical need for cultural shift and fosters collaborations between SCM practitioners and pharmaceutical scientists
With a thorough exploration of SCM from beginning to end of the pharmaceutical process, this book helps secure responsive, cost effective, and risk mitigated supply chains to compete on a world stage. |
|
Auf Bestellung (Lieferzeit unbekannt)
Newsfeed | 
Facebook | 
Twitter
